Physician profile
Leon Maynard Shechtman
NPI 1487669057
$1,654.19
in general payments reported to CMS, 2019-2025
14 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.77 · 2020: $60.80 · 2021: $196 · 2022: $551 · 2023: $216 · 2024: $265 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $723 · Entertainment: $26.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.93 |
| Entertainment | $26.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $371.32 | 2019-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Astellas Pharma US INC | $232.94 | 2024-2025 | Izervay |
| Bausch & Lomb Americas INC. | $230.25 | 2022-2023 | Infuse |
| Sight Sciences, INC. | $123.57 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $121.88 | 2022 | |
| Mallinckrodt Hospital Products INC. | $120.00 | 2025 | Acthar |
| Kala Pharmaceuticals, INC. | $95.92 | 2021 | |
| Glaukos Corporation | $93.12 | 2022 | |
| New World Medical,INC. | $83.73 | 2023 | |
| Coopervision INC. | $66.49 | 2024 | Misight Contact Lens |
| Rxsight INC | $38.46 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Johnson & Johnson Vision Care, INC. | $31.36 | 2024 | |
| Thea Pharma INC. | $27.81 | 2023 | Iyuzeh |
| Tarsus Pharmaceuticals, INC. | $17.34 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Shechtman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.